Brighthouse Financial (BHF) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
6 Aug, 2026Executive summary
Net income available to shareholders was $956 million ($16.53 per diluted share) for Q2 2026, up from $60 million ($1.02 per diluted share) in Q2 2025, reflecting significant year-over-year growth.
Adjusted earnings were $258 million ($4.45 per diluted share), up from $198 million ($3.43 per diluted share) year-over-year, with no notable items impacting the quarter.
The increase was driven by favorable changes in variable annuity and Shield hedges, higher investment yields, and lower claims in Run-off and Life segments.
Annuity sales totaled $2.4 billion, primarily driven by record Shield Level Annuities sales exceeding $2.1 billion; life sales were $39 million, led by SmartCare.
A merger agreement with Aquarian Capital/Aquarian Holdings is pending, with all conditions met except for certain insurance regulatory approvals; the merger is expected to close in 2026.
Financial highlights
Total revenues for Q2 2026 were $1.62 billion, up from $871 million in Q2 2025; six-month revenues were $3.15 billion, slightly down from $3.26 billion year-over-year.
Net investment income for Q2 2026 was $1.24 billion, compared to $1.29 billion in Q2 2025.
Adjusted net investment income yield was 4.17% for Q2 2026.
Book value per common share, excluding AOCI, increased to $156.10 from $144.09 year-over-year.
Corporate expenses were $204 million, up $2 million year-over-year but down $23 million sequentially.
Outlook and guidance
Management anticipates continued volatility in net income due to differences between hedge targets and GAAP reserves, which are sensitive to market performance.
The company expects continued volatility from capital markets, interest rates, and inflation, which may impact investment portfolio performance and product demand.
Management believes it has sufficient liquidity and capital to meet business requirements under current and stress scenarios.
Forward-looking statements highlight risks related to the pending merger with Aquarian Capital LLC, regulatory approvals, and potential business disruptions.
Latest events from Brighthouse Financial
- All board-recommended proposals passed, including director elections and Say-on-Pay.BHF
AGM 2026 - Net loss widened to $792M, adjusted earnings rose, and the Aquarian merger remains on track.BHF
Q1 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.BHF
Proxy filing - Pending merger, record sales, and strong governance define this year's proxy highlights.BHF
Proxy filing - Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 2025 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 2024 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 2024